At an age when most teenagers are focused on school assignments and hobbies, Siddharth Nandyala has captured global attention for developing an AI-powered healthcare technology that could transform how heart diseases are detected.
The Indian-origin tech prodigy, based in Texas, USA, became internationally recognized after creating Circadian AI, a smartphone-based cardiac screening platform capable of identifying potential heart abnormalities in just seven seconds. His achievement has drawn praise from government leaders, healthcare professionals, technology experts, and innovation communities worldwide.
Who is Siddharth Nandyala?
Siddharth Nandyala is a young entrepreneur, AI researcher, and STEM advocate of Indian origin whose family traces its roots to Anantapur, Andhra Pradesh.
Despite being only 14 years old, Siddharth has already established himself as one of the youngest innovators working at the intersection of artificial intelligence and healthcare technology.
His passion for coding, machine learning, and medical innovation began at an early age. Over time, he combined these interests to develop solutions aimed at making healthcare faster, more accessible, and affordable.
His work has attracted attention from policymakers and healthcare organizations because it addresses one of the world’s biggest public health challenges—cardiovascular disease.
Circadian AI: Siddharth’s Groundbreaking Invention
Siddharth’s most notable invention is Circadian AI, an artificial intelligence-powered diagnostic screening application designed to detect early signs of cardiovascular disease through heart sound analysis.
The technology works by recording a patient’s heartbeat using a smartphone microphone. Advanced AI and machine-learning algorithms then analyze the acoustic patterns and compare them against known indicators of heart abnormalities.
Looking for answers to your specific business questions? Our experts provide customized FREE platform to you. Contact us at: https://www.towardshealthcare.com/contact-us
Within approximately seven seconds, the platform generates a screening result that can help identify individuals who may require further medical evaluation.
Unlike traditional cardiac diagnostics that often require expensive medical equipment, hospital visits, ECGs, or echocardiograms, Circadian AI aims to provide a fast, low-cost preliminary assessment using only a smartphone.
This approach could be particularly valuable in rural communities and developing regions where access to cardiologists and advanced diagnostic facilities remains limited.
How Does the Technology Work?
The AI platform follows a multi-step process:
1. Heart Sound Collection
The smartphone microphone captures heart sounds, including subtle acoustic signals often missed during routine examinations.
2. Signal Processing
Background noise is filtered out, and the heartbeat data is converted into analyzable digital patterns.
3. AI Pattern Recognition
Machine-learning models evaluate thousands of heart sound characteristics and compare them with previously trained datasets.
4. Risk Prediction
The system identifies patterns associated with cardiac abnormalities and produces a screening result in seconds.
The objective is not to replace doctors but to act as an early-warning system that enables faster medical intervention.
Clinical Testing and Performance Statistics
According to publicly reported data, Circadian AI has undergone large-scale testing across both the United States and India.
Reported Performance Metrics
| Metric | Reported Value |
|---|---|
| Screening Time | 7 Seconds |
| Accuracy Rate | 96%+ |
| U.S. Patient Testing | 15,000+ Patients |
| India Patient Testing | 3,500+ Patients |
| Total Evaluations | 18,500+ Patients |
The reported accuracy level of over 96% has been one of the key reasons the innovation gained international attention.
However, healthcare experts continue to emphasize the importance of peer-reviewed validation and independent clinical studies before widespread medical adoption.
Why This Innovation Matters
Cardiovascular disease remains the leading cause of death globally.
According to the World Health Organization (WHO):
- More than 17.9 million people die from cardiovascular diseases annually.
- Cardiovascular conditions account for approximately 32% of all global deaths.
- Nearly 85% of cardiovascular deaths result from heart attacks and strokes.
In India, cardiovascular diseases contribute to nearly 28% of all deaths, making early detection a major healthcare priority.
The ability to identify potential heart problems within seconds using a smartphone could significantly improve screening accessibility, especially in underserved populations.
Recognition from Governments and Industry Leaders
Siddharth’s innovation has received recognition from multiple government and industry stakeholders.
The young inventor met Andhra Pradesh Chief Minister N. Chandrababu Naidu, who praised his contribution to healthcare technology and encouraged further innovation.
Reports also indicate recognition from members of the U.S. House of Representatives for his contributions to STEM education and technological advancement.
His work has become an example of how young innovators can contribute meaningful solutions to real-world healthcare challenges.
Beyond Circadian AI
Before developing Circadian AI, Siddharth reportedly worked on a low-cost prosthetic arm designed to improve accessibility for individuals requiring prosthetic support.
He has also expressed interest in expanding AI-powered sound analysis to detect respiratory conditions such as:
- Pneumonia
- Pulmonary embolism
- Lung disorders
- Other cardiovascular complications
This broader vision positions him not just as a young inventor but as a healthcare technology entrepreneur focused on preventive diagnostics.
The Future of Siddharth Nandyala’s Innovation
Siddharth Nandyala’s journey demonstrates the growing power of artificial intelligence in healthcare. His invention shows how smartphones, machine learning, and medical science can be combined to create potentially life-saving screening tools.
While further clinical validation and regulatory approvals will determine the long-term impact of Circadian AI, the reported results—96% accuracy, over 18,500 patient evaluations, and seven-second screening capability—have already made Siddharth one of the most talked-about young innovators in the global healthcare technology landscape.
His work represents a future where early disease detection could become faster, more affordable, and accessible to millions worldwide.
Access our exclusive, data-rich dashboard dedicated to the healthcare market – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Healthcare WebWire is a part of Towards Healthcare Research and Consulting is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium